Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (127)

« Back to Publications

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses

Yang H. et al, (2021), Cell Reports, 35, 109103 - 109103

Characterizing Hepatitis C Virus–Specific CD4+ T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure

Hartnell F. et al, (2020), Hepatology, 72, 1541 - 1555

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

Esposito I. et al, (2020), Science Translational Medicine, 12

ntiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

Fidler S. et al, (2020), The Lancet, 395, 888 - 898

multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins

Hancock G. et al, (2019), Scientific Reports, 9

bstracts of the 17th European AIDS Conference, Basel, Switzerland, 6-9 November 2019.

(2019), HIV medicine, 20 Suppl 9, 3 - 316

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection

Zilber E. et al, (2019), AIDS, 33, 1253 - 1256

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).

Mothe B. et al, (2019), EClinicalMedicine, 11, 65 - 80

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers

Rosás-Umbert M. et al, (2019), Journal of Virology, 93

MS‐Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments

Andreatta M. et al, (2019), PROTEOMICS, 19

Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

Hartnell F. et al, (2019), Frontiers in Immunology, 9

Lessons from the Research in Viral Eradication of Reservoirs (RIVER) study: Impact of a therapeutic vaccine targeting conserved HIV epitopes on T cell function in treated primary infection

Kopycinski J. et al, (2019), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 22, 20 - 21

MHC-II invariant chain adjuvanted chimpanzee adenoviral and MVA hepatitis C vaccines elicit unprecedented levels of anti-viral T-cell immune responses in humans

Esposito I. et al, (2019), JOURNAL OF HEPATOLOGY, 70, E3 - E4

Oral abstracts of the 22nd International AIDS Conference, 23–27 July 2018, Amsterdam, the Netherlands

(2018), Journal of the International AIDS Society, 21

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

López-Camacho C. et al, (2018), Nature Communications, 9

Load More

1
2
3
4
5
6
7
...
»